Description
This oral capsule presents 5-Amino-1MQ, a small-molecule NNMT inhibitor connected to NAD+ and methylation metabolism, in a solid-dose research format.
Laboratory studies in fat-cell cultures and animal models have explored NNMT blockade, adipocyte energy use, NAD+ salvage activity, and metabolic rate. The oral capsule format supports route-of-delivery and metabolic research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.